Cardiorenal syndrome (CRS) represents a bidirectional interplay between cardiac and renal dysfunction, but CRS cases involving paediatric patients represent only a minority of cases overall. CRS type‐4 (CRS4), a long‐term reno‐cardiac syndrome driven by chronic kidney disease (CKD), is not the most frequently reporte...
Mohammed AbuBaha, S. Aldwaik, Ahmad Nouri et al.· Nephrology· 0 citations
BACKGROUND
The clinical benefit of intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) in patients with unprotected left main coronary artery disease (ULMCAD) remains uncertain. We performed an updated meta-analysis of randomized controlled trials (RCTs) comparing IVUS-guided versus angiogra...
A. Emara, A. Awashra, A. Mansour et al.· International Journal of Car...· 0 citations
BACKGROUND
Stroke prevention after transcatheter aortic valve replacement (TAVR) in patients with atrial fibrillation remains clinically challenging because thromboembolic risk must be balanced against substantial bleeding vulnerability. Left atrial appendage occlusion (LAAO) has been proposed as a nonpharmacologic alt...
Mustafa Abomohsen, Amr Elboliney, A. Mohamed et al.· Journal of Cardiology· 0 citations
Baxdrostat lowers blood pressure and aldosterone levels in uncontrolled and resistant hypertension but increases potassium and modestly reduces eGFR, supporting careful laboratory monitoring and longer trials to evaluate long-term clinical outcomes.
A. Gadelmawla, A. Hageen, R. Rateb et al.· Cardiology in Review· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.